BRIEF published on 10/08/2026 at 19:57, 1 month 3 days ago Mauna Kea Technologies: First Half 2026 Review International Market Mauna Kea Technologies 2026 Financial Results Cellvizio Innovation Expansion CellTolerance
BRIEF published on 10/08/2026 at 19:57, 1 month 3 days ago Mauna Kea Technologies Reports 2026 Mid-Year Financial Results Financial Results Revenue Growth U.S. Market Strategy CellTolerance Expansion 2027 Financial Visibility
PRESS RELEASE published on 10/08/2026 at 19:52, 1 month 3 days ago Inside Information / Other news releases Mauna Kea Technologies reports 2026 Half-Year Results with strong revenue growth and improved gross margin, extending financial visibility to 2027 Revenue Growth Mauna Kea Technologies Cellvizio Financial Visibility 2026 Half-Year Results
BRIEF published on 08/26/2026 at 17:50, 2 months 16 days ago Mauna Kea Technologies: Advances in the diagnosis of digestive cancers Mauna Kea Technologies Endomicroscopy Meta-analysis NECA Digestive Cancers
BRIEF published on 08/26/2026 at 17:50, 2 months 16 days ago Mauna Kea Technologies Highlights Meta-Analysis on Cellvizio's Clinical Impact Mauna Kea Technologies Cellvizio Meta-analysis Upper Gastrointestinal Cancer PCLE
PRESS RELEASE published on 08/26/2026 at 17:45, 2 months 16 days ago Inside Information / Other news releases Mauna Kea Technologies announces publication of a landmark systematic review and meta-analysis reinforcing the diagnostic accuracy and clinical impact of Cellvizio in upper gastrointestinal cancer Mauna Kea Technologies Cellvizio Meta-analysis Upper Gastrointestinal Cancer Systematic Review
BRIEF published on 08/07/2026 at 17:50, 3 months 4 days ago Mauna Kea Technologies Reports Voting Rights and Share Capital Details Share Capital Voting Rights Euronext Growth AMF Regulations Mauna Kea Technologies
BRIEF published on 08/07/2026 at 17:50, 3 months 4 days ago Mauna Kea Technologies: Voting rights and share capital as of July 31, 2026 Share Capital Voting Rights AMF Euronext Growth Mauna Kea Technologies
PRESS RELEASE published on 08/07/2026 at 17:45, 3 months 4 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Mauna Kea Technologies provides monthly information on voting rights and shares. Cellvizio platform revolutionizing medical diagnostics worldwide Voting Rights Shares Medical Diagnostics Mauna Kea Technologies Cellvizio Platform
BRIEF published on 07/16/2026 at 18:01, 3 months 26 days ago Mauna Kea Technologies to Host a Webinar on First-Half 2026 Business Activity Webinar Financial Community Business Highlights Mauna Kea Technologies Cellvizio®
Published on 11/11/2026 at 19:31, 33 minutes ago Lion Copper Corp. Completes S-K 1300 Technical Report Summary for Bear Copper Deposit
Published on 11/11/2026 at 16:30, 3 hours 34 minutes ago ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 14:25, 5 hours 39 minutes ago Route1 Announces 2026 Annual Meeting Results
Published on 11/11/2026 at 14:00, 6 hours 4 minutes ago PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 6 hours 4 minutes ago NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
Published on 11/11/2026 at 19:29, 35 minutes ago EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 1 hour 23 minutes ago AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/10/2026 at 17:31, 1 day 2 hours ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 1 day 6 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 1 day 9 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 1 day 13 hours ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 2 days 1 hour ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
